21 Mar

Trimethoprim and adverse outcomes in older patients

21 Mar 2018

Members of our group have recently published a paper investigating adverse effects of trimethoprim for the treatment of urinary tract infection. We show that compared to other antibiotics used for the same reason, trimethoprim is associated with an increased risk of acute kidney injury  (a sudden reduction in kidney function) and high potassium levels but not an increased risk of death. Both of...

11 Sep

International Conference on Pharmacoepidemiology and Therapeutic Risk Management – Montreal Aug 2017

11 Sep 2017

Sam Wilkinson & Ian Douglas     Sam’s thoughts: As a new student of pharmacoepidemiology- and a first-time attendee of ICPE- I was initially overwhelmed. All the sessions seemed relevant and interesting, and the first challenge was to use the time efficiently. By the end though, I felt encouraged. My research focuses on Type 2 Diabetes drugs, and I spent most of my time attending...

31 Jul

Where did statistical software come from?

31 Jul 2017

Sarah C Gadd, John Tazare A hugely important part of studying the epidemiology of diseases is being able to use statistics appropriately. Members of the Electronic Health Records group often write code in statistical programming languages in order to process and analyse data, but we rarely discuss how these programs came to exist. A number of developments in computer science were led by a desire...

16 Jun

Barriers and facilitators to linking and sharing routine health data for research

16 Jun 2017

Today Dr Charlotte Warren-Gash discusses ‘Barriers and facilitators to linking and sharing routine health data for research’ on the PHG Foundation blog’

24 Apr

Report from 1st EDEN Forum

24 Apr 2017

By Anna Ascott School researcher, Dr Sinéad Langan helped organise the first European Dermatology Epidemiology Network (EDEN) Forum, which was held on 30-31 March 2017, in Madrid, Spain  Dermato-Epidemiology, which describes the study of causes, prevention, health services research and evaluation of interventions of skin diseases, is particularly important for dermatology, as a relatively...

19 Apr

Blog – Availability of clinical trial data for research purposes

19 Apr 2017

By Kevin Wing. I recently attended a session entitled EMA’s Policy on Clinical Publication: Opportunities, Challenges and Measuring Success at the Drug Information Association annual conference in Glasgow, (still just about) UK, focusing on progress of the European Medicines Agency’s (EMA) new policy for making complete clinical trial data available for access by the public and researchers...

10 Apr

PHE Conference and ISPE mid-year meeting

10 Apr 2017

by Andreia Leite. Members of the electronic health records (EHR) group have recently attended two conferences:  Public Health England (PHE) Research and Applied Epidemiology Scientific Conference 2017 and ISPE 2017 mid-year meeting. In both, researchers from the group presented work using data from the Clinical Practice Research Datalink (CPRD). PHE conference joined professionals working in...

3 Jan

Funding secured to investigate the effect of partner bereavement on skin diseases

03 Jan 2017

The European Academy of Dermatology and Venerology are funding a programme of work to investigate the effects of partner bereavement on a range of skin diseases. The project is being led by Dr Sinéad Langan and is a collaboration between the LSHTM EHR Research Group, Aarhus University in Denmark and the Clinical Practice Research Datalink. A number of EHR researchers from LSHTM are involved in...

8 Nov

Prize at Biennial Conference of the International Society of Hypertension, Seoul, South Korea, September 2016.

08 Nov 2016

At the end of September, Sarah-Jo Sinnott travelled to Seoul, South Korea to attend and present at the International Society of Hypertension conference. This society has members from all over the world, and the biennial conference provides a forum for the presentation and discussion of all research relating to hypertension, from basic science to clinical science to epidemiological...

27 Sep

Comorbidites in patients with chronic kidney disease – Masao Iwagami

27 Sep 2016

In August 2016, our monthly Journal Club featured a Nephrology article entitled “Comorbidity as a driver of adverse outcomes in people with chronic kidney disease” (M Tonelli et al., Kidney Int., 2015 [88], 859-66). Chronic kidney disease (CKD), defined as kidney damage (albuminuria or proteinuria) or as decreased kidney function (estimated glomerular filtration rate [eGFR] <60...

6 Sep

ICPE 2016, Dublin

06 Sep 2016

by Anthony Matthews and Sarah-Jo Sinnot Members of the EHR group recently travelled to the 32nd International Conference on Pharmacoepidemiology and Therapeutic Risk Management in Dublin. Not only were several members presenting both talks and posters (see table below), the group also held a successful symposium entitled ‘Optimal Use of Data from United Kingdom Electronic Health Records’